782 Survival in advanced-stage ovarian carcinoma with high VEGF-A expression after addition of bevacizumab. Results from the German ICON7 patient cohort | Zendy

AI Assistant Blog Pricing

782 Survival in advanced-stage ovarian carcinoma with high VEGF-A expression after addition of bevacizumab. Results from the German ICON7 patient cohort

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.